PREVAIL is a clinical trial designed to determine whether an investigational new drug, obicetrapib, can reduce the risk of serious cardiovascular events (like a heart attack or stroke) in individuals with Cardiovascular Disease.
February 4th has been set aside as a day we celebrate Go Red for Women. Watch the video below and learn how you can help increase enrollment of women in cardiovascular trials such as the PREVAIL study.
Diversity, Equity, and Inclusion for the PREVAIL study
